Wall Street Journal Pro Capital: Health-Care VCs Emerge from Tech Investors’ Shadow
Back Bay’s Managing Partner and CEO, Jonathan Gertler was quoted in the WSJ Venture Pro Capital article: “Health-Care VCs Emerge from Tech Investors’ Shadow. Dr. Gertler commented that drug manufacturers once depended on products that could draw billions of dollars in sales. New blockbusters will still emerge, but instead of relying on them, corporations aim to build more diverse portfolios.
Read more at the WSJ (Subscription may be required).